Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation

Trial Profile

Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation

Completed
Phase of Trial: Phase 0

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms FAME-05
  • Sponsors CONRAD
  • Most Recent Events

    • 27 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 05 Jun 2015 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
    • 05 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top